Cargando…
Radiomics Signature: A potential biomarker for the prediction of survival in Advanced Hepatocellular Carcinoma
Objectives: To develop and validate radiomics nomograms for the pretreatment predictions of overall survival (OS) and time to progression (TTP) in the patients with advanced hepatocellular carcinoma (HCC) treated with apatinib plus transarterial chemoembolization (TACE), and to assess the incrementa...
Autores principales: | Li, Lingli, Kan, Xuefeng, Zhao, Yongjun, Liang, Bo, Ye, Tianhe, Yang, Lian, Zheng, Chuansheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100633/ https://www.ncbi.nlm.nih.gov/pubmed/33967603 http://dx.doi.org/10.7150/ijms.55510 |
Ejemplares similares
-
Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: Monotherapies and Combined Therapies
por: Ouyang, Tao, et al.
Publicado: (2022) -
Association of clinical and radiographic findings with the outcomes of 93 patients with COVID-19 in Wuhan, China
por: Li, Lingli, et al.
Publicado: (2020) -
Advanced Hepatocellular Carcinoma With Hepatic Arterioportal Shunts: Combination Treatment of Transarterial Chemoembolization With Apatinib
por: Sun, Tao, et al.
Publicado: (2020) -
Spleen Radiomics Signature: A Potential Biomarker for Prediction of Early and Late Recurrences of Hepatocellular Carcinoma After Resection
por: Li, Pinxiong, et al.
Publicado: (2021) -
Radiomics signature: A potential biomarker for β-arrestin1 phosphorylation prediction in hepatocellular carcinoma
por: Che, Feng, et al.
Publicado: (2022)